Literature DB >> 25362185

Successful use of Alteplase during cardiopulmonary resuscitation following massive PE in a patient presenting with ischaemic stroke and haemorrhagic transformation.

Robert Middleton1, Juliane Neumann1, Simon Michael Ward1.   

Abstract

The management of patients with acute stroke regarding treatment of thromboembolism is supported by a limited evidence base. We present the case of a 55-year-old female patient who initially presented with an ischaemic cerebral infarct with haemorrhagic transformation. Her clinical recovery was complicated by cardiac arrest secondary to massive pulmonary embolism. This was successfully treated with cardiopulmonary resuscitation and thrombolysis using Alteplase, which led to a full recovery to the pre-arrest state with no evidence of haemorrhagic complication. The patient was successfully discharged to a specialist centre for on-going stroke rehabilitation with no additional neurological impact. Despite the limited evidence base we believe this case highlights that thrombolysis can be used in select patients with haemorrhagic transformation of stroke and serious thromboembolic complications to achieve a positive outcome. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25362185      PMCID: PMC4216893          DOI: 10.1136/bcr-2013-200480

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  33 in total

1.  Patent foramen ovale: innocent or guilty? Evidence from a prospective population-based study.

Authors:  Irene Meissner; Bijoy K Khandheria; John A Heit; George W Petty; Sheldon G Sheps; Gary L Schwartz; Jack P Whisnant; David O Wiebers; Jody L Covalt; Tanya M Petterson; Teresa J H Christianson; Yoram Agmon
Journal:  J Am Coll Cardiol       Date:  2005-12-06       Impact factor: 24.094

Review 2.  Venous thromboembolism after acute stroke.

Authors:  J Kelly; A Rudd; R Lewis; B J Hunt
Journal:  Stroke       Date:  2001-01       Impact factor: 7.914

Review 3.  Risk factors for intracranial hemorrhage in acute ischemic stroke patients treated with recombinant tissue plasminogen activator: a systematic review and meta-analysis of 55 studies.

Authors:  William N Whiteley; Karsten Bruins Slot; Peter Fernandes; Peter Sandercock; Joanna Wardlaw
Journal:  Stroke       Date:  2012-09-20       Impact factor: 7.914

4.  Hemorrhagic transformation of ischemic brain tissue: asymptomatic or symptomatic?

Authors:  C Berger; M Fiorelli; T Steiner; W R Schäbitz; L Bozzao; E Bluhmki; W Hacke; R von Kummer
Journal:  Stroke       Date:  2001-06       Impact factor: 7.914

Review 5.  Prevention of venous thromboembolism after acute ischemic stroke.

Authors:  P W Kamphuisen; G Agnelli; M Sebastianelli
Journal:  J Thromb Haemost       Date:  2005-06       Impact factor: 5.824

6.  Thirty-day case-fatality rates for pulmonary embolism in the elderly.

Authors:  R M Siddique; M I Siddique; A F Connors; A A Rimm
Journal:  Arch Intern Med       Date:  1996-11-11

7.  Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.

Authors:  Werner Hacke; Markku Kaste; Erich Bluhmki; Miroslav Brozman; Antoni Dávalos; Donata Guidetti; Vincent Larrue; Kennedy R Lees; Zakaria Medeghri; Thomas Machnig; Dietmar Schneider; Rüdiger von Kummer; Nils Wahlgren; Danilo Toni
Journal:  N Engl J Med       Date:  2008-09-25       Impact factor: 91.245

8.  Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators.

Authors:  W Hacke; M Kaste; C Fieschi; R von Kummer; A Davalos; D Meier; V Larrue; E Bluhmki; S Davis; G Donnan; D Schneider; E Diez-Tejedor; P Trouillas
Journal:  Lancet       Date:  1998-10-17       Impact factor: 79.321

9.  Duration of resuscitation efforts and survival after in-hospital cardiac arrest: an observational study.

Authors:  Zachary D Goldberger; Paul S Chan; Robert A Berg; Steven L Kronick; Colin R Cooke; Mingrui Lu; Mousumi Banerjee; Rodney A Hayward; Harlan M Krumholz; Brahmajee K Nallamothu
Journal:  Lancet       Date:  2012-09-05       Impact factor: 79.321

10.  Massive pulmonary thromboembolism and stroke.

Authors:  Poobalan Naidoo; Richard Hift
Journal:  Case Rep Med       Date:  2011-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.